RxNorm Semantic Concepts Index - 587
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "587".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 5871 | Insulin protease | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 5871 | Insulin protease | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 5871 | Insulin protease | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 5871 | Insulin protease | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 587251 | Cytokeratin 19 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 587251 | Cytokeratin 19 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 587251 | Cytokeratin 19 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 587251 | Cytokeratin 19 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 587258 | Hb 129(H7), Ala-pro | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 587258 | Hb 129(H7), Ala-pro | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 587258 | Hb 129(H7), Ala-pro | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 587258 | Hb 129(H7), Ala-pro | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 587318 | glycolic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 587741 | Nimotuzumab | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 587741 | Nimotuzumab | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 587875 | Product containing quaternary ammonium compound (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 587875 | Product containing quaternary ammonium compound (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 587875 | Product containing quaternary ammonium compound (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 587875 | Product containing quaternary ammonium compound (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 5879 | Interferon alfa-2a | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 5879 | Interferon alfa-2a | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 5879 | Interferon alfa-2a | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 5879 | Interferon alfa-2a | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 5879 | Interferon alfa-2a | Full form of descriptor (FN) | NO |